ID Name Structure References (top 5) Molecular Target(s)
1ID:215
ALLOISOLEUCINE


NSC#:9252
NSC#:9958
NSC#:23277
NSC#:45691
NSC#:46708
NSC#:46709
NSC#:77687
NSC#:206282
Aldrich#:05703
Aldrich#:05705
Aldrich#:05706
Aldrich#:151718
Aldrich#:162728
Aldrich#:298654
Aldrich#:298689
Aldrich#:340960
Aldrich#:386480
Aldrich#:486817
Aldrich#:488992
Aldrich#:489018
Aldrich#:490059
Aldrich#:490067
Aldrich#:492361
Aldrich#:492388
Aldrich#:492418
Aldrich#:58879
Aldrich#:58880
Aldrich#:58883
Aldrich#:58884
Aldrich#:61819
Aldrich#:61820
Aldrich#:61830
Aldrich#:61840
Aldrich#:855448
Aldrich#:I0380
Aldrich#:I2752
Aldrich#:I3388
Aldrich#:I5393
Aldrich#:I6268
Aldrich#:I7268
Aldrich#:I7383
Aldrich#:I7634
Aldrich#:I8754
Aldrich#:L0389
Aldrich#:L1387
Aldrich#:L1512
Aldrich#:L5652
Aldrich#:L5770
Aldrich#:L5897
Aldrich#:L602
Aldrich#:L7750
Aldrich#:L7772
Aldrich#:L7875
Aldrich#:L8000
Aldrich#:L8125

Freqency:
in 1 ingredients:

  • 159
  • in 62 recipes:

  • 38
  • 52
  • 56
  • 58
  • 64
  • 69
  • 75
  • 80
  • 97
  • 101
  • 110
  • 112
  • 113
  • 114
  • 116
  • 117
  • 121
  • 162
  • 167
  • 172
  • 177
  • 178
  • 179
  • 188
  • 189
  • 195
  • 197
  • 202
  • 219
  • 234
  • 254
  • 256
  • 283
  • 288
  • 289
  • 304
  • 306
  • 312
  • 319
  • 325
  • 342
  • 354
  • 377
  • 381
  • 385
  • 389
  • 390
  • 391
  • 393
  • 394
  • 398
  • 399
  • 400
  • 460
  • 466
  • 467
  • 476
  • 477
  • 481
  • 485
  • 489
  • 501

  • Properties
    C6H13NO2    131.17





    1:  Hendrickson TL, Nomanbhoy TK, de Crecy-Lagard V, Fukai S, Nureki O, Yokoyama S, Schimmel P.
    Mutational separation of two pathways for editing by a class I tRNA synthetase.
    Mol Cell.    impact factor:   18.142
    2002;  9(2): 353-62

    2:  Chan KY, Cheung AN, Yip SP, Ko HH, Lai TW, Khoo US.
    Population-based case-control study of HER2 genetic polymorphism and breast cancer risk.
    J Natl Cancer Inst.    impact factor:   12.945
    2002;  94(20): 1581-2

    3:  Hishida A, Hamajima N, Iwata H, Matsuo K, Hirose K, Emi N, Tajima K.
    Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.
    J Natl Cancer Inst.    impact factor:   12.945
    2002;  94(23): 1807-8

    4:  Kunstle G, Laine J, Pierron G, Kagami Si S, Nakajima H, Hoh F, Roumestand C, Stern MH, Noguchi M.
    Identification of Akt association and oligomerization domains of the Akt kinase coactivator TCL1.
    Mol Cell Biol.    impact factor:   9.866
    2002;  22(5): 1513-25

    5:  Okumura N, Terasawa F, Tanaka H, Hirota M, Ota H, Kitano K, Kiyosawa K, Lord ST.
    Analysis of fibrinogen gamma-chain truncations shows the C-terminus, particularly gammaIle387, is essential for assembly and secretion of this multichain protein.
    Blood.    impact factor:   8.782
    2002;  99(10): 3654-60

    ABL
    ALK
    AKT
    ARG
    BAS
    BAD
    BAX
    C-AMP
    CB-1
    DDR
    EGFR-1
    EGFR-2
    FAS
    FGF-2
    FGFR-3
    FYN
    HSC
    HCK
    HGF
    KDR
    KIT
    LC
    LRP
    MER
    MET
    MDR1
    NM-23
    P38
    P21
    P53
    P450
    PI-3K
    PTP-A
    RET
    Rho GTPase
    S-100
    SHP-1
    SHP-2
    STEP
    SRC
    THYMIDINE KINASE
    THYMIDYLATE SYNTHASE
    THYMIDYLATE SYNTHETASE
     
    Time used: 453 milliseconds.

    Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005